196 related articles for article (PubMed ID: 19900544)
1. Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity.
Swaminathan S; Pastero L; Serpe L; Trotta F; Vavia P; Aquilano D; Trotta M; Zara G; Cavalli R
Eur J Pharm Biopharm; 2010 Feb; 74(2):193-201. PubMed ID: 19900544
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study.
Ansari KA; Vavia PR; Trotta F; Cavalli R
AAPS PharmSciTech; 2011 Mar; 12(1):279-86. PubMed ID: 21240574
[TBL] [Abstract][Full Text] [Related]
3. Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability assessment.
Swaminathan S; Vavia PR; Trotta F; Cavalli R
J Biomed Nanotechnol; 2013 Jun; 9(6):998-1007. PubMed ID: 23858964
[TBL] [Abstract][Full Text] [Related]
4. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
Shende PK; Gaud RS; Bakal R; Patil D
Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium.
Zidan MF; Ibrahim HM; Afouna MI; Ibrahim EA
Drug Dev Ind Pharm; 2018 Aug; 44(8):1243-1253. PubMed ID: 29452493
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy.
Lembo D; Swaminathan S; Donalisio M; Civra A; Pastero L; Aquilano D; Vavia P; Trotta F; Cavalli R
Int J Pharm; 2013 Feb; 443(1-2):262-72. PubMed ID: 23279938
[TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin complexation: influence on the solubility, stability, and cytotoxicity of camptothecin, an antineoplastic agent.
Kang J; Kumar V; Yang D; Chowdhury PR; Hohl RJ
Eur J Pharm Sci; 2002 Mar; 15(2):163-70. PubMed ID: 11849913
[TBL] [Abstract][Full Text] [Related]
8. Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability.
Gabr MM; Mortada SM; Sallam MA
Eur J Pharm Sci; 2018 Jan; 111():1-12. PubMed ID: 28931488
[TBL] [Abstract][Full Text] [Related]
9. CDI cross-linked β-cyclodextrin nanosponges of paliperidone: synthesis and physicochemical characterization.
Sherje AP; Surve A; Shende P
J Mater Sci Mater Med; 2019 Jun; 30(6):74. PubMed ID: 31197491
[TBL] [Abstract][Full Text] [Related]
10. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrin based nanosponges for pharmaceutical use: a review.
Tejashri G; Amrita B; Darshana J
Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin-based nanosponge for improvement of solubility and oral bioavailability of Ellagic acid.
Mady FM; Ibrahim SR
Pak J Pharm Sci; 2018 Sep; 31(5(Supplementary)):2069-2076. PubMed ID: 30393214
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery.
Cirpanli Y; Bilensoy E; Lale Doğan A; Caliş S
Eur J Pharm Biopharm; 2009 Sep; 73(1):82-9. PubMed ID: 19442723
[TBL] [Abstract][Full Text] [Related]
15. Degree of crosslinking in β-cyclodextrin-based nanosponges and their effect on piperine encapsulation.
Guineo-Alvarado J; Quilaqueo M; Hermosilla J; González S; Medina C; Rolleri A; Lim LT; Rubilar M
Food Chem; 2021 Mar; 340():128132. PubMed ID: 33011468
[TBL] [Abstract][Full Text] [Related]
16. Improving the solubility and in vitro cytotoxicity (anticancer activity) of ferulic acid by loading it into cyclodextrin nanosponges.
Rezaei A; Varshosaz J; Fesharaki M; Farhang A; Jafari SM
Int J Nanomedicine; 2019; 14():4589-4599. PubMed ID: 31296988
[No Abstract] [Full Text] [Related]
17. Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells.
Minelli R; Cavalli R; Ellis L; Pettazzoni P; Trotta F; Ciamporcero E; Barrera G; Fantozzi R; Dianzani C; Pili R
Eur J Pharm Sci; 2012 Nov; 47(4):686-94. PubMed ID: 22917641
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of solubility enhancement, antioxidant activity, and cytotoxicity studies of kynurenic acid loaded cyclodextrin nanosponge.
Dhakar NK; Caldera F; Bessone F; Cecone C; Pedrazzo AR; Cavalli R; Dianzani C; Trotta F
Carbohydr Polym; 2019 Nov; 224():115168. PubMed ID: 31472867
[TBL] [Abstract][Full Text] [Related]
19. Release modulation and cytotoxicity of hydroxycamptothecin-loaded electrospun fibers with 2-hydroxypropyl-beta-cyclodextrin inoculations.
Xie C; Li X; Luo X; Yang Y; Cui W; Zou J; Zhou S
Int J Pharm; 2010 May; 391(1-2):55-64. PubMed ID: 20170717
[TBL] [Abstract][Full Text] [Related]
20. Pyromellitic dianhydride crosslinked cyclodextrin nanosponges for curcumin controlled release; formulation, physicochemical characterization and cytotoxicity investigations.
Rafati N; Zarrabi A; Caldera F; Trotta F; Ghias N
J Microencapsul; 2019 Dec; 36(8):715-727. PubMed ID: 31530203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
